Broadwood Partners Reports Ownership Change in Insight Molecular Diagnostics
Ticker: IMDX · Form: 4 · Filed: Apr 27, 2026 · CIK: 0001642380
| Field | Detail |
|---|---|
| Company | Insight Molecular Diagnostics Inc. (IMDX) |
| Form Type | 4 |
| Filed Date | Apr 27, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Broadwood Partners changed its stake in Insight Molecular Diagnostics. Details in filing.
AI Summary
On April 23, 2026, Broadwood Partners, L.P. reported a change in beneficial ownership of securities for Insight Molecular Diagnostics Inc. The filing, made on April 27, 2026, details transactions related to the issuer's stock. Specific details of the transactions, including the number of shares and dollar amounts, are available within the full filing.
Why It Matters
This filing indicates a change in significant holdings by a major investor, which could signal shifts in confidence or strategy regarding Insight Molecular Diagnostics Inc.
Risk Assessment
Risk Level: medium — Form 4 filings can indicate insider trading or significant shifts in institutional ownership, which may impact stock price.
Key Players & Entities
- Broadwood Partners, L.P. (company) — Reporting entity
- Insight Molecular Diagnostics Inc. (company) — Issuer
- Broadwood Capital Inc. (company) — Related entity
- Bradsher Neal C (person) — Related person
FAQ
What is the CIK for Broadwood Partners, L.P.?
The CIK for Broadwood Partners, L.P. is 0001278386.
What is the CIK for Insight Molecular Diagnostics Inc.?
The CIK for Insight Molecular Diagnostics Inc. is 0001642380.
What is the filing date of this Form 4?
The filing date of this Form 4 is 2026-04-27.
What is the period of report for this filing?
The period of report for this filing is 2026-04-23.
What is the business address for Broadwood Capital Inc.?
The business address for Broadwood Capital Inc. is 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 27, 2026 by Bradsher Neal C regarding Insight Molecular Diagnostics Inc. (IMDX). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.